Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Jul 25;320:183. doi: 10.1016/j.ijcard.2020.07.030

HIIT: A potential rehabilitation treatment in COVID-19 pneumonia with heart disease

Yunzhao Li a, Di Liu a, Hui Wu a,b,
PMCID: PMC7833490  PMID: 32721412

Dear Editor,

Recently, Keech and his colleagues provided a clinical trial that High-intensity interval training (HIIT) could reduce the cardiovascular risk of coronary artery disease (CAD) patients during cardiac rehabilitation and may improve the quality of life of such patients in the long term [1].

Way et al. [2] also believed that low-volume HIIT could improve cardiovascular health in patients with type 2 diabetes. HIIT has been shown to promote the formation of coronary collateral circulation, enhanced mitochondrial muscle function, repaired vascular endothelial cells and reduced chemokine chemotaxis [3]. It not only relieved the prognosis of CAD patients but also reduced the occurrence of angina pectoris. Exercise-induced myocardial protection could promote nitric oxide signal transduction and ATP-dependent potassium channel function, increase the activity of endoplasmic reticulum stress protein and myocardial COX-2 [4]. Besides, the latest research found that HIIT could cause elevated plasma and myocardial Klotho protein levels, by reducing myocardial TRPC6 expression, enhancing antioxidant defense, promoting myocardial protection, and reducing myocardial ischemia-reperfusion injury [5]. It has illustrated scientific evidence for HIIT.

The outbreak of COVID-19 has brought significant medical challenges in the world. Many infected patients suffered severe neurological, psychological and cardiac disabilities due to the virus. HIIT may be a potential beneficiary of cardiac rehabilitation therapy for patients with COVID-19 infection after discharge from the hospital, which would improve the quality of life in survivors and improve long-term prognosis. These patients will participate in social activities at an early date.

Declaration of Competing Interest

None.

Acknowledgements

This work was supported by National Natural Science Foundation of China (81600234).

References

  • 1.Keech A., Holgate K., Fildes J. High-intensity interval training for patients with coronary artery disease: finding the optimal balance. Int. J. Cardiol. 2020;298:8–14. doi: 10.1016/j.ijcard.2019.09.060. [DOI] [PubMed] [Google Scholar]
  • 2.Way K.L., Sabag A., Sultana R.N. The effect of low-volume high-intensity interval training on cardiovascular health outcomes in type 2 diabetes: a randomised controlled trial. Int. J. Cardiol. 2020;S0167-5273:33397–33400. doi: 10.1016/j.ijcard.2020.06.019. [DOI] [PubMed] [Google Scholar]
  • 3.Batacan R.B., Jr., Duncan M.J., Dalbo V.J. Effects of high-intensity interval training on cardiometabolic health: a systematic review and meta-analysis of intervention studies. Br. J. Sports Med. 2017;51:494–503. doi: 10.1136/bjsports-2015-095841. [DOI] [PubMed] [Google Scholar]
  • 4.Powers S.K., Smuder A.J., Kavazis A.N. Mechanisms of exercise-induced cardioprotection. Physiology (Bethesda) 2014;29:27–38. doi: 10.1152/physiol.00030.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ramez M., Ramezani F., Nasirinezhad F. High-intensity interval training increases myocardial levels of Klotho and protects the heart against ischaemia-reperfusion injury. Exp. Physiol. 2020;105:652–665. doi: 10.1113/EP087994. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Cardiology are provided here courtesy of Elsevier

RESOURCES